| FT. MYERS, Fla., Dec. 6, 2011 /PRNewswire/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it was revising upward its previously issued revenue guidance for Quarter 4, 2011. The Company now expects revenue of approximately $12.0 - $12.5 million in the fourth quarter, an increase from the original guidance of $11.4 - $12.0 million released on October 19, 2011. The Company also re-iterated that it expects to be profitable in Quarter 4 with net income of $0.00 to $0.01 per ...continued NGNM Healthcare 541711 labcorp |
Tuesday, December 6, 2011
NeoGenomics Announces Upward Revisions to its Q4 2011 Revenue Guidance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment